Ocean Biomedical 株価情報 (NASDAQ: OCEA)

最新ニュース Ocean Biomedical (NASDAQ:OCEA) 株価情報

Ocean Biomedical

Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.

Ocean Biomedical Inc

Ocean Protocol - United States Dollar

Ocean Park High Income ETF

Ocean Park International ETF

Ocean Power Technologies, Inc. Common Stock

Ocean Power Technologies Inc

OCEAN SPRAY 4 PR by Ocean Spray Cranberries, Inc.

Ocean Spray Cranberries Inc

OCEAN THERMAL ENERGY CORP by Ocean Thermal Energy Corp.

Ocean Thermal Energy Corp

OceanFirst Financial Corp. - Common Stock

OceanFirst Financial Corp

OceanFirst Financial Corp. - Depositary Shares

OceanPal Inc

OceanTech Acquisitions I Corp

OceanTech Acquisitions I Corp Units (1 Ord Class A & 1 War)

OceanTech Acquisitions I Corp Warrants (12/05/2026)

OceanTech Acquisitions I Corp Class A

Oceana Group Ltd

OceanaGold Corp

OCEANAGOLD (PHILIPPINES) by OCEANAGOLD (PHILIPPINES) INC.

OceanaGold Philippines Inc

Oceaneering International, Inc. Common Stock

Oceaneering International Inc

OCEANIA HEALTHCARE LTD by Oceania Healthcare Ltd.

Oceania Healthcare Ltd

OCEANIC IRON ORE CORP NEW by Oceanic Iron Ore Corp.

Oceanic Iron Ore Corp

OCEANIC WIND ENERGY INC. by Oceanic Wind Energy Inc.

Oceanic Wind Energy Inc

OCEANSIX FUTURE PATHS LTD by OCEANSIX FUTURE PATHS LTD.

Oceansix Future Paths Ltd

Anthropic, a leading AI company <a href="https://www.benzinga.com/24/11/42141911/amazon-and-anthropic-deepen-4-billion-ai-partnership-with-claude-35-launch">backed by Amazon</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NYSE">AMZN</a>) and <a href="https://www.benzinga.com/government/24/10/41528255/googles-2b-investment-in-anthropic-under-scrutiny-uk-opens-competition-inquiry">Google</a>, is reportedly having a seemingly contradictory stance on artificial intelligence. While the company actively promotes AI use in the workplace and develops AI-driven hiring tools, it has a strict rule for job seekers: do not use AI when applying for their positions.
<h2 class="wp-block-heading">The Double Standard</h2>
As an individual noticed and Futurism reported on, Anthropic's job application form explicitly states:
&#8220;While we encourage people to use AI systems during their role to help them work faster and more effectively, please do not use AI assistants during the application process. We want to understand your personal interest in Anthropic without mediation through an AI system, and we also want to evaluate your non-AI-assisted communication skills.&#8221;
Don't Miss:
<ul>
<li>Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs-nancy-pelosi">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>
The company profits from AI-powered hiring processes yet restricts candidates from using the same tools to improve their chances in an increasingly competitive job market. Meanwhile, AI is being widely adopted across hiring processes, with 98.4% of Fortune 500 companies using AI to filter applications and 43% of companies either using or planning to use AI for interviews, according to Jobscan.&nbsp;
<h2 class="wp-block-heading">Anthropic's AI Ambitions</h2>
Anthropic is at the forefront of AI development, <a href="https://www.benzinga.com/news/24/06/39426605/google-amazon-backed-openai-rival-anthropic-unveils-claude-3-5-sonnet-its-most-powerful-ai-yet">competing with OpenAI</a> and other major players. The company recently saw its annualized revenue surge to $1 billion, a tenfold increase from the previous year. It is also reportedly <a href="https://www.benzinga.com/25/01/43127416/anthropic-gains-big-with-google-backing-aiming-for-60-billion-valuation-and-surging-ai-revenue">securing $2 billion in funding</a>, which could triple its valuation to $60 billion.
Backed by Amazon's $8 billion investment and Google's recent $1 billion contribution, Anthropic is pushing forward with AI advancements. CEO Dario Amodei <a href="https://www.benzinga.com/markets/25/01/43094410/jeff-bezos-backed-anthropic-ceo-predicts-ai-will-surpass-human-intelligence-by-2027-but-warns-to-watch-out-for-negative-consequences">has predicted</a> that AI could surpass human intelligence within two to three years. He recently stated that Artificial General Intelligence—AI with human-level capabilities—could emerge by 2026 or 2027, barring setbacks like data shortages, GPU production issues, or scalability problems.
Trending: Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a>
While AI companies like Anthropic push for rapid advancements, they also set rules that seem to favor employers over job seekers. The rise of AI-driven hiring has already overwhelmed recruiters, leading to a cycle where companies turn to AI to sort through AI-generated applications.
Anthropic's policy highlights a growing concern. AI is being used to reshape the job market, but workers are being told they can't use it to compete. As both sides of hiring increasingly rely on AI, critics argue that companies must set fair and transparent standards—or risk creating a system where only employers benefit from AI's efficiencies.
For now, if you're applying to Anthropic, leave AI out of it. But once you're hired, feel free to use it all you want.
Read Next:
<ul>
<li>Built on the trusted network of Fortune 500 companies, <a href="https://www.benzinga.com/money/web3-enabler-the-most-boring-blockchain-company-partners-with-salesforce">this blockchain company partners with Salesforce to uproot lengthy and expensive B2B transactions, and you can invest with just $100.</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
</ul>

News

AMZN

Amazon And Google-Backed AI Firm Anthropic Urges Job Seekers: Please Don't Use AI To Apply Here

Humana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) has outperformed the market over the past 20 years by 2.35% on an annualized basis producing an average annual return of 10.76%. Currently, Humana has a market capitalization of $30.99 billion. 
Buying $100 In HUM: If an investor had bought $100 of HUM stock 20 years ago, it would be worth $764.30 today based on a price of $257.34 for HUM at the time of writing.
<h3>Humana's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739317568_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much You Would Have Made Owning Humana Stock In The Last 20 Years

NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) has outperformed the market over the past 20 years by 28.85% on an annualized basis producing an average annual return of 37.26%. Currently, NVIDIA has a market capitalization of $3.26 trillion. 
Buying $100 In NVDA: If an investor had bought $100 of NVDA stock 20 years ago, it would be worth $62,469.62 today based on a price of $133.02 for NVDA at the time of writing.
<h3>NVIDIA's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739316646_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

NVDA

$100 Invested In NVIDIA 20 Years Ago Would Be Worth This Much Today

<a href="https://www.benzinga.com/startups/25/01/43391017/2-trillion-by-2026-elon-musks-ambitious-push-to-reinvent-government-spending-with-silicon-valley-powerhouses">Elon Musk</a> isn't worried about Donald Trump stopping the rise of electric cars. In fact, he thinks it's impossible. "At this point, I think that sustainable transport is inevitable," Musk told investors.&nbsp;
Musk compared the shift to EVs to the transition from horse-drawn carriages to automobiles. "Even if you were the biggest horse advocate on Earth, you couldn't stop the advent of the automobile. And you can't stop the advent of electric cars," he said on a call late last month to discuss Tesla's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) latest quarterly results.&nbsp;&nbsp;
The biggest hurdle for EVs used to be range, but Musk says that's no longer an issue. With more charging infrastructure and better battery technology, people aren't as hesitant to switch. Still, the political scene is shifting, and some wonder what that means for Tesla and the industry as a whole.&nbsp;&nbsp;
Don't Miss:
<ul>
<li>Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs-nancy-pelosi">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>
One of Trump's first moves in office was to undo Joe Biden's goal of having 50% of new car sales be electric by 2030. He also wants to get rid of the federal EV tax credit, which gives buyers up to $7,500 in incentives.&nbsp;
That could make EVs a harder sell, but Musk isn't too concerned. In fact, he's actually in favor of ending those subsidies.&nbsp;
"Take away the subsidies. It will only help Tesla," <a href="https://x.com/elonmusk/status/1813112958157005259?lang=en">he said on X </a>last July. His argument? Tesla has already built a strong EV business, while other automakers still rely on incentives to stay competitive.&nbsp;&nbsp;
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a>
That doesn't mean everything is smooth sailing for Tesla. According to Electrive, EV sales in the U.S. grew by only 7.3% in 2024, reaching 1.3 million units. That's just a slight bump from 7.8% to 8.1% of total car sales. Meanwhile, Tesla's own sales dropped by 5.6% to 633,762 vehicles—their first annual decline in over a decade.&nbsp;&nbsp;
But Musk believes Tesla's real edge isn't just in electric cars; it's in self-driving technology. "There is a path where Tesla is worth more than the next top five car companies combined&#8230; and that is overwhelmingly due to autonomous vehicles and autonomous humanoid robots," he said on the Jan. 30 earnings call.&nbsp;&nbsp;&nbsp;
See Also: <a href="https://www.benzinga.com/money/elon-musk-told-the-u-n-if-they-could-show-a-plan-for-ending-world-hunger-hed-donate-6-billion-i-will-sell-tesla-stock-right-now-and-do-it">Elon Musk Told The U.N. If They Could Show A Plan For Ending World Hunger He'd Donate $6 Billion – ‘I Will Sell Tesla Stock Right Now And Do It'</a>
Tesla is also making adjustments based on new policy changes. For example, the company had planned to expand into Mexico, but Musk recently put that on hold after <a href="https://www.benzinga.com/startups/25/02/43493701/fed-chair-jerome-powell-faces-trumps-pressure-the-president-cant-fire-me-as-interest-rates-hold-steady-at-4-25-4-5">Trump </a>suggested heavy tariffs on Mexican-made cars. "Trump has said that he will put heavy tariffs on vehicles produced in Mexico, so it doesn't make sense to invest in Mexico," Musk said on a separate earnings call in July amid the 2024 presidential campaign.&nbsp;
Despite these challenges, Tesla isn't slowing down. The company is rolling out a driverless ride-hailing service in Austin within the next six months and is on track to produce autonomous "cybercabs" by 2026. It's also planning to unveil a working prototype of their Optimus humanoid robot in 2025.&nbsp;&nbsp;
Read Next:
<ul>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>

Startups

TSLA

Elon Musk: 'You Can't Stop The Advent Of Electric Cars'—Says EV Success Is As Inevitable As Cars Replacing Horses

Jones Trading analyst Jason Weaver maintains Rithm Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RITM#NYSE">RITM</a>) with a Buy and maintains $12.5 price target.

Price Target

Analyst Ratings

RITM

Jones Trading Maintains Buy on Rithm Capital, Maintains $12.5 Price Target

Barrington Research analyst Gary Prestopino maintains Liquidity Services (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LQDT#NASDAQ">LQDT</a>) with a Outperform and maintains $40 price target.

LQDT

Barrington Research Maintains Outperform on Liquidity Services, Maintains $40 Price Target

Offerings

Flowers Foods Prices Public Offering Of $500M Of 5.750% Senior Notes Due 2035 And $300M Of 6.200% Senior Notes Due 2055

Baker Hughes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>) has outperformed the market over the past 5 years by 5.19% on an annualized basis producing an average annual return of 17.64%. Currently, Baker Hughes has a market capitalization of $46.70 billion. 
Buying $1000 In BKR: If an investor had bought $1000 of BKR stock 5 years ago, it would be worth $2,143.31 today based on a price of $47.19 for BKR at the time of writing.
<h3>Baker Hughes's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739313918_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Baker Hughes Stock In The Last 5 Years

Macquarie analyst Steve Koenig maintains Datadog (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>) with a Outperform and maintains $200 price target.

DDOG

Macquarie Maintains Outperform on Datadog, Maintains $200 Price Target

HIVE Digital Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIVE#NASDAQ">HIVE</a>) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.11) by 109.09 percent. This is a 112.5 percent increase over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $29.23 million which beat the analyst consensus estimate of $26.50 million by 10.30 percent. This is a 6.47 percent decrease over sales of $31.25 million the same period last year.

Earnings

Earnings Beats

HIVE

HIVE Digital Technologies Q3 EPS $0.01 Beats $(0.11) Estimate, Sales $29.23M Beat $26.50M Estimate

Hexcel Prices Offering Of $300M Of Unsecured 5.875% Senior Notes Due 2035

Spire Global Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPIR#NYSE">SPIR</a>) shares are sinking in Tuesday&#8217;s after-hours session after it filed a c<a href="https://www.benzinga.com/news/asset-sales/24/11/41944207/spire-global-soars-on-heels-of-241-million-sale-of-maritime-business-plans-debt-payoff">omplaint against Kpler Holding</a>.
What Happened: In a new filing released after the market close on Tuesday, Spire Global announced that it filed a complaint in the Delaware Court of Chancery alleging Kpler failed to close on the <a href="https://www.benzinga.com/news/asset-sales/24/11/41944207/spire-global-soars-on-heels-of-241-million-sale-of-maritime-business-plans-debt-payoff">acquisition of Spire&#8217;s maritime business</a>.
Spire Global entered into a purchase agreement with Kpler in November to sell its maritime business for a cash payment based on an enterprise value of $233.5 million. The company said at the time that it expected the transaction to close in the first quarter. 
Spire Global said it believes all conditions in the purchase agreement have been satisfied or could be satisfied. The company also noted that Kpler agreed to "use best efforts, and to take any and all actions necessary&#8221; to consummate the transaction.
&#8220;The Company believes that Buyer's failure to close is not consistent with the terms of the Purchase Agreement, which do not give Buyer the option to delay closing once all closing conditions have been met,&#8221; Spire Global said in the filing.
See Also: <a href="https://www.benzinga.com/news/earnings/25/02/43641962/lyft-q4-earnings-revenue-beat-gross-bookings-up-15-new-buyback-our-biggest-competition-is-inertia">Lyft Q4 Earnings: Revenue Beat, Gross Bookings Up 15%, New Buyback — &#8216;Our Biggest Competition Is Inertia&#8217;</a>
As a result, Spire Global asked the courts to order Kpler to satisfy the purchase agreement obligations and close the deal.
&#8220;There is no assurance as to what action the Delaware Court of Chancery will take with respect to the proceeding initiated by the Company and there is no assurance as to whether or not the Transactions will be consummated on the terms contemplated or at all,&#8221; the company said.
Price Action: <a href="http://benzinga.com/quote/spir">Spire Global shares</a> were down 43.8% at $11.15 in Tuesday&#8217;s after-hours session at the time of publication, per <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/news/25/02/43637482/trump-gaza-cherish-it-white-house-meeting-with-jordans-king-abdullah">Trump Says We Will &#8216;Take Gaza&#8217; And &#8216;Cherish It&#8217; In White House Meeting With Jordan&#8217;s King Abdullah</a></li>
</ul>
This illustration was generated using artificial intelligence via Midjourney.

Movers

SPIR

Spire Global Stock Is Plunging After Hours: What's Going On?

Travelers Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>) has outperformed the market over the past 20 years by 1.28% on an annualized basis producing an average annual return of 9.69%. Currently, Travelers Companies has a market capitalization of $54.92 billion. 
Buying $1000 In TRV: If an investor had bought $1000 of TRV stock 20 years ago, it would be worth $6,299.71 today based on a price of $242.35 for TRV at the time of writing.
<h3>Travelers Companies's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739313152_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Travelers Companies 20 Years Ago Would Be Worth Today

Lifeway was an early investor in Simple Foods in 2015 and since that time, the Company has already realized a $1.5 million gain in 2019, bringing the total expected net proceeds to Lifeway of approximately $6.5 million.

LWAY

Lifeway Foods Expects To Realize Approximately $5M Of Net Profit Due To Recently Announced Sale Of Simple Foods To Flowers Foods

Marc Fogel, who <a href="https://www.benzinga.com/markets/cannabis/22/06/27780092/russia-sentences-60-something-former-us-diplomat-to-14-years-for-cannabis-possession" target="_blank" rel="noreferrer noopener">was sentenced to 14 years</a> in a Russian penal colony after his 2021 arrest in Moscow for possessing medical marijuana, is coming home.
The White House announced Tuesday, per various news outlets, that it had negotiated Fogel's release.
White House national security adviser Michael Waltz said that Steve Witkoff, President Donald Trump&#8216;s special envoy to the Middle East, was leaving Russian airspace with Fogel, who was declared "wrongfully detained" by President Joe Biden shortly before he left the White House.
Waltz said <a href="https://www.benzinga.com/markets/cannabis/24/08/40111778/russia-prisoner-swap-senators-demand-inclusion-of-cannabis-prisoner-marc-fogel-mom-takes-antony-">Fogel</a>, who previously worked at the&nbsp;U.S. embassy in Moscow and also as an English teacher, would be on U.S. soil by Tuesday night.
&#8220;President Trump, Steve Witkoff and the president&#8217;s advisors negotiated an exchange that serves as a show of good faith from the Russians and a sign we are moving in the right direction to end the brutal and terrible war in Ukraine,&#8221; he said in a statement, <a href="https://www.cbsnews.com/news/marc-fogel-released-russia-trump/">cited</a> by CBS News.
In what CNN <a href="https://www.cnn.com/2025/02/11/politics/marc-fogel-released-russia-trump/index.html">referred</a> to as an extraordinary move, Witkoff personally went to Russia to bring back Fogel, the statement indicated. There has been no known high-level U.S. travel to Russia since the start of the war in Ukraine in February 2022.
"By tonight, Marc Fogel will be on American soil and reunited with his family and loved ones thanks to President Trump's leadership," Waltz's statement said.
Fogel's family <a href="https://www.cnn.com/2025/02/11/politics/marc-fogel-released-russia-trump/index.html">said</a> Tuesday they "are beyond grateful, relieved, and overwhelmed that after more than three years of detention" he is coming home.
"Thanks to the unwavering leadership of President Trump, Marc will soon be back on American soil, free where he belongs," Jane, Ethan and Sam Fogel said in a statement.
Fogel was a legal medical marijuana patient in Pennsylvania where he used cannabis as an alternative to opioids for chronic pain following spinal surgery.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/02/43639754/ukraine-floats-land-swap-with-russia-as-trump-signals-peace-push">Ukraine Floats Land Swap With Russia As Trump Signals Peace Push</a></li>
</ul>
Photo: Melnikov Dmitriy/Shutterstock.com

Cannabis

Government

Politics

Global

Trump Administration Secures Release Of Cannabis Prisoner Marc Fogel From 14-Year Russian Sentence

SWTX

SpringWorks Secures FDA Approval Of GOMEKLI For Treatment Of Adult And Pediatric Patients With NF1-PN

Similarweb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMWB#NYSE">SMWB</a>) sees FY2025 sales of $285.000 million-$288.000 million vs $285.99 million analyst estimate.

Guidance

SMWB

Similarweb Sees FY2025 Sales $285.000M-$288.000M vs $285.99M Est

Similarweb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMWB#NYSE">SMWB</a>) sees Q1 sales of $66.000 million-$66.500 million vs $67.36 million analyst estimate.

Similarweb Sees Q1 Sales $66.000M-$66.500M vs $67.36M Est

Similarweb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMWB#NYSE">SMWB</a>) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.04 by 25 percent. This is a 50 percent decrease over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $65.59 million which beat the analyst consensus estimate of $65.42 million by 0.25 percent. This is a 15.56 percent increase over sales of $56.76 million the same period last year.

Earnings Misses

Similarweb Q4 Adj $0.03 Misses $0.04 Estimate, Sales $65.59M Beat $65.42M Estimate

Streaming giant Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) has opened a new restaurant experience in Las Vegas as part of its continuing efforts to diversify its revenue thanks to<a href="https://www.benzinga.com/general/entertainment/23/08/33994201/netflix-could-have-secret-weapon-to-manage-the-hollywood-strikes-cooking-shows-and-a-new-re"> loyal fan bases.</a>
What Happened: Netflix Bites Vegas is the newest restaurant imagined by Netflix, which has <a href="https://www.benzinga.com/general/entertainment/23/10/35097694/netflix-and-chill-buy-our-merch-streaming-giant-ready-to-make-money-with-new-consumer-produ">opened limited time restaurants</a> before that feature menu dishes inspired by the company's shows and movies.
The restaurant is <a href="https://mgmgrand.mgmresorts.com/en/restaurants/netflix-bites.html">located </a>in the Las Vegas MGM Grand Hotel &amp; Casino, which is operated by MGM Resorts International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGM#NYSE">MGM</a>).
Open to the public, customers do not have to be staying at the hotel or going to the casino to take part in the restaurant dining <a href="https://www.prnewswire.com/news-releases/netflix-bites-is-now-open-302373916.html">options</a>. Walk-ins are open with reservations opening on Feb. 20. The restaurant is planned to open for one year and has breakfast, lunch and dinner options.
"This one-of-a-kind restaurant combines Netflix's storytelling with MGM Grand's renowned hospitality, offering an unforgettable culinary journey crafted to give fans a new way to experience their favorite stories and characters," the company said.
The menu was unveiled this week with a variety of options including sandwiches, burgers, seafood, salads, sides, desserts and drinks. Many of the menu items have names that pay tribute to Netflix shows and movies, including:
<ul>
<li>Queen Charlotte's Fruit Trees</li>
<li>Bridgerton Regency Tea</li>
<li>Eggs Benedict Bridgerton</li>
<li>Stranger Things Eleven's Feast</li>
<li>Finny &amp; Georgia's Peaches Foster</li>
<li>Get Your Knives Out For This Glass Onion</li>
<li>Stranger Wings</li>
<li>WWE Smashburger</li>
<li>Beverly Hills Cobb</li>
<li>Selling Caesar Salad</li>
<li>To All The Tomato Soups I've Loved Before</li>
<li>Squid Game Red Bite, Green Bite</li>
<li>Is It (Cheese) Cake</li>
<li>The Dessert Is Lava</li>
</ul>
The restaurant is open daily for breakfast and lunch from 7 a.m. to 2 p.m. local time and from 5 p.m. to 10 p.m. Sunday through Thursday and 5 p.m. to 12 a.m. Friday and Saturday for dinner.
Read Also: <a href="https://www.benzinga.com/news/earnings/25/01/43114866/netflix-q4-earnings-record-subscribers-nfl-squid-game-push-past-highest-expectations">Netflix Q4 Earnings: Record Subscribers, NFL, &#8216;Squid Game&#8217; Push Past &#8216;Highest Expectations&#8217;</a>
Why It's Important: Netflix Bites in Las Vegas follows the streaming company's successful Netflix Bites Los Angeles, which had fully booked reservations in 2023 as a pop-up restaurant.
The streaming company has ventured further into experiences that can provide diversification opportunities and ways to expand on the company's original brands.
This includes having experiences for "Bridgerton," "Stranger Things" and "Squid Game" previously.
Netflix is also opening "experiential entertainment venues" at Texas and Pennsylvania <a href="https://www.benzinga.com/general/entertainment/24/06/39439112/will-netflix-save-shopping-malls-new-experiences-a-potential-game-changer-for-retail-center">shopping malls this year </a>that will offer restaurants with food inspired by Netflix shows and sell merchandise from the company's shows and movies.
The company said it has reached 7.5 million fans across 170 openings in 100 cities around the world for its various experiences.
NFLX Price Action: Netflix stock was down 1.9% to $1,008.80 on Tuesday versus a 52-week trading range of $542.01 to $1,032.85. Netflix stock is up 81% over the last year.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42751367/netflix-posts-record-debut-with-squid-game-season-2-heres-how-many-people-watched-show">Netflix Posts Record Debut With &#8216;Squid Game&#8217; Season 2: Here&#8217;s How Many People Watched Show</a></li>
</ul>

Entertainment

Restaurants

NFLX

Netflix Stock Near All-Time Highs: New Las Vegas Restaurant With Food Inspired By Stranger Things, Squid Game & More Could Diversify Revenue

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth checking out as we dive into all of the biggest news sending shares higher and lower on Wednesday morning!



Moving stocks this morning are delisting notices, an acquisition plan, a public share offering and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Sify Technologies Limited &ndash; Rights (NASDAQ:<a href="https://investorplace.com/stock-quotes/sifyr-stock-quote/">SIFYR</a>) are rocketing more than 49% <a href="https://www.nasdaq.com/articles/sify-technologies-sets-ads-rights-delisting-date">ahead of their delisting next week</a>.</li>



<li>Golden Heaven (NASDAQ:<a href="https://investorplace.com/stock-quotes/gdhg-stock-quote/">GDHG</a>) stock is soaring over 47% with heavy pre-market trading.</li>



<li>Wang &amp; Lee (NASDAQ:<a href="https://investorplace.com/stock-quotes/wlgs-stock-quote/">WLGS</a>) shares are surging close to 40% with strong early morning trading.</li>



<li>Singing Machine (NASDAQ:<a href="https://investorplace.com/stock-quotes/mics-stock-quote/">MICS</a>) stock is gaining more than 29% <a href="https://www.nasdaq.com/press-release/singing-machine-acquire-semicab-leading-ai-logistics-technology-company-2024-06-12">on acquisition news</a>.</li>



<li>Castellum (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ctm-stock-quote/">CTM</a>) shares are increasing nearly 25% this morning.</li>



<li>Beamr Imaging (NASDAQ:<a href="https://investorplace.com/stock-quotes/bmr-stock-quote/">BMR</a>) stock is rising over 23% after <a href="https://seekingalpha.com/news/4115034-beamr-imaging-product-now-on-oracle-cloud-marketplace-shares-jump-30?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain%7Csection%3Aon-the-move">adding its product</a> to a new marketplace.</li>



<li>Molecular Partners (NASDAQ:<a href="https://investorplace.com/stock-quotes/moln-stock-quote/">MOLN</a>) shares are climbing more than 16% as they continue to rise on <a href="https://www.nasdaq.com/press-release/molecular-partners-and-orano-med-share-positive-preclinical-data-their-dll3-0">positive preclinical data</a>.</li>



<li>Surf Air Mobility (NYSE:<a href="https://investorplace.com/stock-quotes/srfm-stock-quote/">SRFM</a>) stock is jumping over 15% on Wednesday morning.</li>



<li>Ocean Biomedical (NASDAQ:<a href="https://investorplace.com/stock-quotes/ocea-stock-quote/">OCEA</a>) shares are heading 15% higher this morning.</li>



<li>NovaBay Pharmaceuticals (NYSEMKT:<a href="https://investorplace.com/stock-quotes/nby-stock-quote/">NBY</a>) stock is up more than 12% today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>ThermoGenesis (NASDAQ:<a href="https://investorplace.com/stock-quotes/thmo-stock-quote/">THMO</a>) stock is plummeting over 41% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318387950&amp;type=PDF&amp;symbol=THMO&amp;cdn=c35080a0c43a3214912906647bd85f4c&amp;companyName=ThermoGenesis+Holdings+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-11">on a delisting notice</a>.</li>



<li>Tonix Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/tnxp-stock-quote/">TNXP</a>) shares are diving almost 32% on a <a href="https://www.nasdaq.com/press-release/tonix-pharmaceuticals-announces-proposed-public-offering-2024-06-11">proposed public offering</a>.</li>



<li>U-BX Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/ubxg-stock-quote/">UBXG</a>) stock is tumbling more than 26% after rallying yesterday.</li>



<li>Clene (NASDAQ:<a href="https://investorplace.com/stock-quotes/clnn-stock-quote/">CLNN</a>) shares are taking an over 24% beating on Wednesday morning.</li>



<li>KWESST Micro Systems (NASDAQ:<a href="https://investorplace.com/stock-quotes/kwe-stock-quote/">KWE</a>) stock is sliding more than 22% <a href="https://investorplace.com/2024/06/why-is-kwesst-micro-systems-kwe-stock-up-121-today/">after rallying yesterday</a>.</li>



<li>Nauticus Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/kitt-stock-quote/">KITT</a>) shares are retreating over 19% <a href="https://investorplace.com/2024/06/why-is-nauticus-robotics-kitt-stock-up-59-today/">after yesterday&rsquo;s rally</a>.</li>



<li>Blue World Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/bwaq-stock-quote/">BWAQ</a>) stock is falling more than 17% after rising higher yesterday.</li>



<li>Chanson International (NASDAQ:<a href="https://investorplace.com/stock-quotes/chsn-stock-quote/">CHSN</a>) shares are dropping over 16% this morning.</li>



<li>Mercurity Fintech (NASDAQ:<a href="https://investorplace.com/stock-quotes/mfh-stock-quote/">MFH</a>) stock is slipping more than 13% today.</li>



<li>Oblong (NASDAQ:<a href="https://investorplace.com/stock-quotes/oblg-stock-quote/">OBLG</a>) shares close out our pre-market stock movers down over 13%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-june-12th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Ocean Biomedical receives non-compliance notice from Nasdaq

Ocean Biomedical (OCEA) just unveiled an update. Ocean Biomedical has been notified by Nasdaq of non-compliance due to its failure to file the mand...

Ocean Biomedical Faces Nasdaq Compliance Challenges

Ocean Biomedical (OCEA) announced that it received a letter from Nasdaq stating that on April 18, May 22 and August 19, staff notified the company ...

Ocean Biomedical receives noncompliance letter from Nasdaq

Ocean Biomedical receives Nasdaq's delisting letter

Ocean Biomedical receives notice from Nasdaq regarding late filing

The latest update is out from Ocean Biomedical ( ($OCEA) ). Ocean Biomedical, Inc. faces potential delisting from Nasdaq after failing to file its ...

Ocean Biomedical Faces Nasdaq Delisting Threat

Ocean Biomedical (OCEA) announced that its Scientific Co-founder, Dr. Jonathan Kurtis, MD, PhD, and his research team have received additional sign...

Ocean Biomedical advances malaria vaccine research with new funding, pathway

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include:&nbsp...

Biotech Alert: Searches spiking for these stocks today

Ocean Biomedical (OCEA) announced newly published research findings demonstrating the ability of its proprietary cancer immunotherapy candidates to...

Ocean Biomedical announces findings in EGFR-mutant lung cancer

BWAQ

CHSN

CLNN

CRGX

GDHG

KITT

LPTX

MICS

MOLN

NLSP

OBLG

OCEA

RGLS

SABS

SIFYR

SLXN

SRFM

SXTP

TECX

TELO

THMO

TNXP

UBXG

WLGS

Press Releases

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON-0200, for HBV Functional Cure, at EASL 2024

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company's Malaria Treatment and Prevention Platforms

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor and Related Tissue Remodeling Responses

Molecure (WSE: MOC) and Nasdaq-listed biotechnology company Ocean Biomedical (NASDAQ: OCEA) sign an exclusive licensing agreement for the development and commercialization of selective YKL-40 inhibitors.

Comments

Ocean Biomedical

ニュース

最新ニュース Ocean Biomedical (NASDAQ:OCEA) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル